New AFCB shares issued

[Kenya Cherrie]

30 years ago, obviously.

 

[CherryBare]

Isn't that a drop?

Not sure maths is his strong point, I assume he meant 1,263.40 which is a 46000% increase

 

[Neil Dawson]

I don't think it matters.
I have held shares in this company for years, I won't be buying anymore as I don't believe in having all my eggs in one basket. All I would say is this company produces medicin people need, and are the world leaders in the insulin market. so the share price is not going to plummet any time soon.
I also invest in shipping, a large company that also show profits of over 20% each year.

Should I Buy A Stock Before It Splits?

Should I Buy A Stock Before It Splits? A split merely adjusts the number of shares currently outstanding which, in turn, adjusts the price of each share.

financhill.com

Yes. I’ve been in and out of novo over the years for the reasons you state. I’m trying to work out if the split is a good thing when’s the best time to go back in as currently am not holding. Any thoughts on that well received you can dm me on that if you prefer not to answer in here

 

[Kenya Cherrie]

I know that the new Ozempic pen is in such demand that there is a waiting list for it,
Novo can't keep up and have just built a new production plant to try and keep up with demand.
Overweight media stars have started using it and now everybody overweight wants it.

Ozempic is a once-weekly injectable medication formulated to help adults with type 2 diabetes manage their blood sugar. Although not officially a weight loss drug, research suggests that people who take Ozempic may lose modest amounts of weight while on the medication. In fact, the active ingredient in Ozempic, known as semaglutide, is FDA-approved at higher doses for treating individuals living with obesity and other weight related medical problems under the name Wegovy.

Due to a Wegovy shortage coupled with Ozempic’s weight loss effects going viral on social media, people without type 2 diabetes have begun using Ozempic off-label for weight loss.
I think the fig below tells you what you need to know. profit and more profit

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments.

Novo Nordisk Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2023	154.6923	135.9024	189.1700	131.3180	184.6500	37.50%
2022	108.1022	106.3519	134.2949	91.0136	134.2949	22.65%
2021	86.2457	68.5268	114.4562	64.3344	109.4900	63.39%
2020	61.7280	54.7948	70.8004	46.4385	67.0110	23.31%
2019	47.7844	43.5527	54.7009	43.1524	54.3441	26.73%
2018	44.4820	49.1101	52.7190	38.6659	42.8825	-11.88%
2017	38.4796	31.5950	48.7202	29.0090	48.6658	54.29%
2016	42.2610	49.0529	50.0965	27.7688	31.5423	-36.56%
2015	45.7997	35.8318	51.5612	35.3343	49.7207	39.32%
2014	37.2863	30.3929	41.3470	30.3929	35.6885	16.69%
2013	28.1623	26.9262	31.5394	24.9205	30.5832	15.44%
2012	23.8200	18.6565	27.6128	18.4172	26.4928	44.10%
2011	18.3898	17.4783	20.9646	15.0866	18.3853	3.90%
2010	13.4865	10.1361	17.6952	9.9369	17.6952	79.47%
2009	8.6586	7.9776	10.7059	6.4810	9.8597	27.03%
2008	9.0690	9.5134	11.0299	6.6485	7.7616	-19.75%
2007	7.9136	6.1337	10.1472	6.0447	9.6715	57.36%
2006	4.9275	4.1145	6.1991	3.9692	6.1462	51.05%
2005	3.8367	3.7760	4.3292	3.5065	4.0690	5.26%
2004	3.4983	2.8914	3.9192	2.7477	3.8658	34.61%
2003	2.4388	2.0294	2.8718	1.7499	2.8718	43.96%
2002	2.1837	2.7416	2.8025	1.5400	1.9949	-27.24%
2001	2.7509	2.4130	3.1607	2.3723	2.7416	14.18%
2000	2.3298	1.8125	3.0549	1.6694	2.4011	37.84%
1999	1.5613	1.8678	1.8678	1.2912	1.7419	-2.00%
1998	1.8721	1.8971	2.2620	1.4468	1.7774	-7.45%
1997	1.4272	1.1926	1.9237	1.1661	1.9205	55.02%
1996	0.9793	0.9224	1.2554	0.8400	1.2389	37.24%
1995	0.7311	0.6115	0.9027	0.5919	0.9027	45.32%

These figs are in Dollars not Danish Kroner.

Wegovy Shortage: Supplies Of Weight-Loss Drug Remain Restricted Amid Booming Sales

Novo Nordisk, which also sells diabetes drug Ozempic, said it is working to build capacity but expects periodic supply constraints for the near future.

www.forbes.com

 

[Kicks_On_66]

I know that the new Ozempic pen is in such demand that there is a waiting list for it,
Novo can't keep up and have just built a new production plant to try and keep up with demand.

My physician is wildly enthusiastic about Ozempic and a similar drug, Mounjaro. He described them as "home runs"* and "maybe the best drugs we have ever had." They are both indicated for diabetes, one of them is also indicated for weight loss, I forget which. My doc said he thinks they will also get indications for hypertension, and maybe some other conditions. He has a patient with some form of leukemia and said the drug has lowered her white blood cell count substanially: "It affects whatever is irritating her bone marrow."
I realize this is quite a diversion from subjects AFCB football, but at least as interesting (to me, anyway) as some of the other diversions.

* Baseball term. It's like a Six in cricket, I believe. Very good.

 

[RobTrent]

ivermectin - Now thats a drug. ;-)

 

[Kicks_On_66]

ivermectin - Now thats a drug. ;-)

Produced a Nobel Prize in Medicine: https://www.forbes.com/sites/judyst...ivermectin-may-fight-malaria/?sh=2812889e6026

 

[purbeck67]

Someone needs to explain this in simple terms for a simple person.
If I have 200 shares @ £10 a share and the company halves them...
do I get 400 shares @ £5 a share (same value)
OR 200 shares @ £5 a share (half the value)...

 

[Kicks_On_66]

Someone needs to explain this in simple terms for a simple person.
If I have 200 shares @ £10 a share and the company halves them...
do I get 400 shares @ £5 a share (same value)
OR 200 shares @ £5 a share (half the value)...

400 @ 5. The value doesn't change. Any benefit would have to be psychological, but management teams seem to love to do them. General Electric did something like a 1:6 reverse split a few years ago, probably hoping that it would help people forget what a dumpster fire GE became.

 

[Kenya Cherrie]

Someone needs to explain this in simple terms for a simple person.
If I have 200 shares @ £10 a share and the company halves them...
do I get 400 shares @ £5 a share (same value)
OR 200 shares @ £5 a share (half the value)...

400 shares @ £5 a share (same value)
It will encourage investers to buy shares as the price before was too high.

 

[Kenya Cherrie]

Yes. I’ve been in and out of novo over the years for the reasons you state. I’m trying to work out if the split is a good thing when’s the best time to go back in as currently am not holding. Any thoughts on that well received you can dm me on that if you prefer not to answer in here

Risen another 6% in the last week , hope you invested.

 

[Kenya Cherrie]

Yes. I’ve been in and out of novo over the years for the reasons you state. I’m trying to work out if the split is a good thing when’s the best time to go back in as currently am not holding. Any thoughts on that well received you can dm me on that if you prefer not to answer in here

Risen another 6% in the last week , hope you invested.

After the share was split it fell slightly but has now recovered and showing a profit of around 10% from the split date. The share has risen fast today after the news of expected profits for the 3rd quarter.

 

[Kenya Cherrie]

Novo Nordisk shares still rising, another 10% since Oct 13th
774.80 now.



Novo Nordisk shares hit a record high on Wednesday, as the Danish pharma group’s blockbuster weight-loss drugs powered a surge in sales and profits last year, cementing its position as Europe’s most valuable company.The Danish group reported that sales climbed 36 per cent to $33.7bn in 2023 while profits rose to almost $15bn, both above analysts’ expectations. Shares rose by 4 per cent to an all-time high in morning trading before falling back, leaving the company hovering around a $500bn market capitalisation for the first time.

Novo Nordisk shares hit record high as weight-loss drugs power profits

Danish drugmaker reports better than expected earnings for 2023

www.ft.com

 

[chriscooke]

Any other tips?

 

[RobTrent]

Any other tips?

I've one ;-)

 

[New Old Cherry]

I don't think it's too wise to be over confident about how all this is going to pan out in the mid/long -term future....OK enjoy it for the Now.

You will observe the position of Lorient in the Frog table......

Personally i'd be as happy to follow Boscombe if we were trotting out at Victoria Park v the Poppies in a local derby circa October 2050...my 100th birthday !

 

[RobTrent]

I don't think it's too wise to be over confident about how all this is going to pan out in the mid/long -term future....OK enjoy it for the Now.

You will observe the position of Lorient in the Frog table......

Personally i'd be as happy to follow Boscombe if we were trotting out at Victoria Park v the Poppies in a local derby circa October 2050...my 100th birthday !

You mean as unhappy surely?

 

[New Old Cherry]

You mean as unhappy surely?

No..because by that time..if we ain't got that Stadium my hopes will be saturated and washed away and all words on it wasted.......
....sooner or later you just have to accept a fate...and be happy.

 

[New Old Cherry]

Speaking of Investments in Football Clubs.....anyone know what's going wrong at Lorient ?..seems no one concerned or mentioning it.....2 Wins from 19 games.....and in Bill Foley's portfolio.......just saying thats all...just saying !

 

[Smidsy]

It’s all part of Bill’s cunning plan. They get relegated and he picks up a majority holding on the cheap.